Effect of Alendronate with β – TCP Bone Substitute in Surgical Therapy of Periodontal Intra-Osseous Defects: A Randomized Controlled Clinical Trial
Introduction: Alendronate (ALN), an aminobisphosphonate, inhibits osteoclastic bone resorption and also stimulates osteogenesis. Beta-Tricalcium Phosphate (β-TCP) is an osteoconductive graft material which provides a scaffold for bone formation and also a widely used drug delivery vehicle for g...
Main Authors: | Rohini Naineni, Vishali Ravi, Dwijendra Kocherlakota Subbaraya, Jammula Surya Prasanna, Veerendranath Reddy Panthula, Rekha Rani Koduganti |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2016-08-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/8365/20965_CE(EK)_F(AK)_PF1(NEAK)_PFA(AK)_PF2(PAG).pdf |
Similar Items
-
Evaluation of an aminobisphosphonate (alendronate) in the management of periodontal osseous defects
by: Veena H, et al.
Published: (2010-01-01) -
Comparison of efficacy of probiotics versus tetracycline fibers as adjuvants to scaling and root planing
by: Lavanya Boyeena, et al.
Published: (2019-01-01) -
Comparison of effectiveness of low-dose aspirin versus omega-3 fatty acids as adjuvants to nonsurgical periodontal therapy in Type II diabetic patients with chronic periodontitis
by: Prathyusha Rampally, et al.
Published: (2019-01-01) -
Chemical vs. herbal formulations as pre-procedural mouth rinses to combat aerosol production: A randomized controlled study
by: Koduganti Rekha Rani, et al.
Published: (2014-01-01) -
Efficacy of an herbal antioxidant as an adjunct to nonsurgical periodontal therapy on procalcitonin levels in smokers with chronic periodontitis
by: M V N Sravya, et al.
Published: (2019-01-01)